(Q34918299)

5 August 2017

1 reference

title

Progress in meeting today's demands in genital herpes: an overview of current management (English)

1 reference

5 August 2017

1 reference

Raj Patel

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

186 Suppl 1

1 reference

5 August 2017

page(s)

S47-56

1 reference

Patients' perspectives on the burden of recurrent genital herpes

5 August 2017

cites work

1 reference

Challenges in genital herpes simplex virus management

21 January 2018

1 reference

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type

21 January 2018

1 reference

The importance of diagnosing genital herpes

21 January 2018

1 reference

Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections

21 January 2018

1 reference

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

21 January 2018

1 reference

Valaciclovir: development, clinical utility and potential

21 January 2018

1 reference

Valaciclovir in the treatment of initial infection by genital herpes virus: comparative study

21 January 2018

1 reference

Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice

21 January 2018

1 reference

Herpes viruses: a background

21 January 2018

1 reference

Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency

21 January 2018

1 reference

The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice

21 January 2018

1 reference

Current recommendations for the treatment of genital herpes.

21 January 2018

1 reference

Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection

21 January 2018

1 reference

Herpes simplex virus: the importance of asymptomatic shedding

21 January 2018

1 reference

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor

21 January 2018

1 reference

Risk Factors for the Sexual Transmission of Genital Herpes

21 January 2018

1 reference

Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study

21 January 2018

1 reference

Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women

21 January 2018

1 reference

Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection

21 January 2018

1 reference

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

21 January 2018

1 reference

HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour.

21 January 2018

1 reference

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

21 January 2018

1 reference

A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group

21 January 2018

1 reference

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

21 January 2018

1 reference

Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial

21 January 2018

1 reference

Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment

21 January 2018

1 reference

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

21 January 2018

1 reference

Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group

21 January 2018

1 reference

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes

21 January 2018

1 reference

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir

21 January 2018

1 reference

Safety of acyclovir: a summary of the first 10 years experience

21 January 2018

1 reference

Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir

21 January 2018

1 reference

Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections

21 January 2018

1 reference

A new look at the shared epitope hypothesis

21 January 2018

1 reference

Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time

21 January 2018

1 reference

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

21 January 2018

1 reference

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

21 January 2018

1 reference

Recurrent erythema multiforme: clinical features and treatment in a large series of patients.

21 January 2018

1 reference

Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir

21 January 2018

1 reference

Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials

21 January 2018

1 reference

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group

21 January 2018

1 reference

Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

21 January 2018

1 reference

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes

21 January 2018

1 reference

Virologic characteristics of subclinical and symptomatic genital herpes infections

21 January 2018

1 reference

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

21 January 2018

1 reference

Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342959

1 reference

5 August 2017

1 reference